These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23357168)

  • 1. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system.
    Antozzi C
    Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to ion channels at the neuromuscular junction.
    Lang B; Vincent A
    Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
    Baggi F; Ubiali F; Nava S; Nessi V; Andreetta F; Rigamonti A; Maggi L; Mantegazza R; Antozzi C
    J Neuroimmunol; 2008 Sep; 201-202():104-10. PubMed ID: 18644634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
    Vernino S; Lennon VA
    Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic autoantibodies to neuronal proteins in neurological disorders.
    Vincent A; Lily O; Palace J
    J Neuroimmunol; 1999 Dec; 100(1-2):169-80. PubMed ID: 10695727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of disorders of neuromuscular transmission.
    Vincent A
    Acta Neurol Scand Suppl; 2006; 183():1-7. PubMed ID: 16637918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seropositive myasthenia and autoimmune autonomic ganglionopathy: cross reactivity or subclinical disease?
    Miglis MG; Racela R; Kaufmann H
    Auton Neurosci; 2011 Oct; 164(1-2):87-8. PubMed ID: 21745762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of neuromuscular transmission disorders.
    Evoli A
    Acta Neurol Scand Suppl; 2006; 183():8-11. PubMed ID: 16637919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for treatment of autoimmune neuromuscular transmission disorders.
    Skeie GO; Apostolski S; Evoli A; Gilhus NE; Illa I; Harms L; Hilton-Jones D; Melms A; Verschuuren J; Horge HW;
    Eur J Neurol; 2010 Jul; 17(7):893-902. PubMed ID: 20402760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune mediated neuromuscular junction defects.
    Farrugia ME; Vincent A
    Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
    Vincent A
    Handb Clin Neurol; 2008; 91():213-27. PubMed ID: 18631844
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis.
    Lazaridis K; Dalianoudis I; Baltatzidi V; Tzartos SJ
    J Neuroimmunol; 2017 Nov; 312():24-30. PubMed ID: 28912035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies, neurotoxins and the nervous system.
    Vincent A; Roberts M; Willison H; Lang B; Newsom-Davis J
    J Physiol Paris; 1995; 89(3):129-36. PubMed ID: 7581302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.